Health Care · Pharmaceutical Preparations · Nasdaq · CIK 1723128 · FYE Dec 31 · Prices AT CLOSE 2026-08-19 (USD) Last $18.11 · Day −0.44% · Mkt cap $5.8B · P/E (FY) 82.7× · 1Y +94.1% · Off 52W high −6.0% · Vol (1Y) 37.6% Price2023-08-21 → 2026-08-19 AMRX close: $3.8 on 2023-08-21 to $18.1 on 2026-08-19. Split-adj closes · 240 of 3,797 · price returnⓘ At a glance | Short interest2.6% of sh out | | Days to cover4.6d | | 13F net flow (QoQ)+1.36% | | Top-10 13F concentration57.6% | | Next report (est.)2026-10-29 |
SI 2026-07-31 · 13F 2026-Q1ⓘ Key fundamentalsFY 2025 | P/E (FY)82.7× | | Sales (TTM)$3.12B | | Earnings (TTM)$157.4M | | Net margin2.4% | | ROIC16.5% | | Sales growth 3Y10.9% |
FY ratios · TTM sales/earnings (USD)ⓘ Trailing returns | YTD+43.7% | | 1Y+94.1% | | 3Y+375.3% | | 5Y+269.6% | | 10Y−22.4% | | Since incept. (ann.)−0.9% |
Total return · from 2011-07-11ⓘ Risk | Ann. volatility (1Y)37.6% | | Ann. volatility (3Y)41.9% | | Sharpe (1Y)1.99 | | Sharpe (3Y)1.47 | | Max drawdown (1Y)−22.3% | | Max drawdown (3Y)−24.6% | | Beta (3Y vs SPY)0.67 |
Daily returns, ann.ⓘ Top institutional holders13F 2026-Q1 | Manager | Shares | Value | % sh out | QoQ |
|---|
| BlackRock, Inc. | 24.5M | $305M | 7.79% | +71.5% | | TPG GP A, LLC | 12.3M | $153M | 3.92% | +0.0% | | VANGUARD PORTFOLIO MANAGEMENT LLC | 11.3M | $141M | 3.60% | new | | Rubric Capital Management LP | 11.0M | $137M | 3.51% | −10.5% | | VANGUARD CAPITAL MANAGEMENT LLC | 7.6M | $94M | 2.41% | new | | STATE STREET CORP | 6.8M | $84M | 2.16% | +65.3% | | DIMENSIONAL FUND ADVISORS LP | 5.7M | $71M | 1.81% | +1.5% | | MORGAN STANLEY | 4.6M | $58M | 1.47% | −3.8% |
Δ vs 2025-Q4ⓘ Latest reported quarterslast report 2026-07-30 | Period end | Reported | EPS | EPS YoY | Revenue | Rev YoY |
|---|
| 2026-06-30 | 2026-07-30 | $0.18 | +157.1% | $796.2M | +9.9% | | 2026-03-31 | 2026-05-07 | $0.19 | +375.0% | $722.5M | +3.9% | | 2025-12-31 | 2026-02-27 | — | — | $814.3M | +11.5% | | 2025-09-30 | 2025-10-30 | $0.01 | — | $784.5M | +11.7% |
As-reported XBRL · next 2026-10-29 est.ⓘ Segment mixFY2025 (ended Dec 2025) Av KARE 58% · Specialty 42% business · TAGGED revenueⓘ Basis & disclosures - EOD closes · nothing imputed or averaged · absent “—”
- As-of differs by block · 13F = US long, 45+d lag, LOWER bound
- Not investment advice · no recommendation, price target or solicitation
- EDGAR + foreign registers · marketstack (licensed EOD) · spzco.com/methodology
| 
